Clinical trial · Interventional
Trial Comparing 19 and 25-gauge EUS-FNA Needles
Multi-Center Randomized Trial Comparing 19 and 25-gauge Needles for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) of Solid Pancreatic Mass Lesions
NCT01677312CI-TRIAL-00044039EUS-FNAcompletedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study compares the 19G and 25G needles for procuring tissue samples from the pancreas during Endoscopic Ultrasound (EUS) procedures.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer of Pancreas | Malignant Pancreatic Neoplasm | ALIAS | 0.90 |
| Pancreatic Neoplasm | Pancreatic Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Histological Samples | Procedure | — | UNRESOLVED |
| Pancreatic Biopsy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- 19G FNA needle
- description
- Evaluate median number of passes to diagnosis (Diagnostic accuracy) and ability to procure histological samples using a 19G FNA needle when performing pancreatic biopsy.
- interventionNames
- Procedure: Pancreatic Biopsy
- Procedure: Histological Samples
- type
- ACTIVE_COMPARATOR
- label
- 25G FNA needle
- description
- Evaluate median number of passes to diagnosis (Diagnostic accuracy) and ability to procure histological samples using a 25G FNA needle when performing pancreatic biopsy.
- interventionNames
- Procedure: Pancreatic Biopsy
- Procedure: Histological Samples
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
INCLUSION CRITERIA: (1) Patients with solid pancreatic mass lesions. EXCLUSION CRITERIA: 1. Age \< 19 years 2. Unable to safely undergo EUS for any reason 3. Coagulopathy (INR \> 1.6, Prothrombin Time \> 18secs, Thrombocytopenia \< 80,000 cells/ml) 4. Unable to consent 5. Non-English speaking patients
References
Publications (0)
Data not yet available
No reference posted for this study.